In this issue:
Non-inferiority of short-course adjuvant therapy in CRC
ERBB genomic alterations in mCRC
Prognostic value of thymidylate synthase expression in CRC
Nivolumab + ipilimumab in mCRC
Primary tumour resection improves survival in mCRC
Biomarker potential of cell-free DNA in rectal cancer
Napabucasin in refractory advanced CRC
Combined inhibition of signalling pathways
Moderate-intensity aerobic exercise in CRC
Please login below to download this issue (PDF)